Every 424B that AMERICAN HEALTHCARE REIT INC (AHR) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 424B covers the supplement that carries the terms of a priced offering, so if you follow AHR and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full AHR filings page.
American Healthcare REIT, Inc. is conducting a follow-on common stock offering of 13,250,000 shares, delivered via forward sale agreements with Morgan Stanley, Citibank and KeyBanc affiliates, at a public offering price of $53.75 per share. Underwriters hold a 30-day option for up to 1,987,500 additional shares. Assuming full physical settlement of the forward sale agreements, the company expects net proceeds of about $707.1 million, or $813.3 million if the option is fully exercised, based on a forward sale price of $53.4176 per share. Proceeds are expected to be contributed to the operating partnership and used primarily to fund an $873 million pending portfolio acquisition of eight senior housing properties and for other investments and general corporate purposes.
American Healthcare REIT, Inc. is conducting a primary offering of 13,250,000 shares of common stock, to be delivered through forward sale agreements with Morgan Stanley, Citibank and KeyBanc affiliates. Underwriters have a 30‑day option for up to 1,987,500 additional shares.
The company expects to physically settle the forwards within ~24 months, issuing shares at an adjusted forward sale price and receiving cash then; it will receive no proceeds from shares initially sold by the forward purchasers. Net proceeds contributed to the operating partnership are expected to help fund an $873,000,000 pending acquisition of eight senior housing properties and other investments, alongside general corporate purposes. Shares outstanding would rise to 231,248,775 after full physical settlement, and REIT charter provisions limit any holder to 9.9% of total capital stock or common stock.
American Healthcare REIT, Inc. is registering 14,000,000 shares of common stock for resale under a forward sale agreement, with an underwriter option increasing the amount to 16,100,000 shares. The underwriter agreed to purchase 14,000,000 shares at an initial forward sale price of $50.005 per share and the offering contemplates physical settlement within approximately 24 months from this prospectus supplement. The company will not receive proceeds from the forward purchaser’s immediate sale; however, assuming full physical settlement and after estimated expenses, the company estimates net proceeds of approximately $699.4 million (or $804.4 million if the option is exercised in full), which it expects to contribute to its Operating Partnership for general corporate purposes.
American Healthcare REIT, Inc. proposes a forward-sale offering of 14,000,000 shares of its common stock (or 16,100,000 shares if the underwriter’s option is exercised in full) through a forward purchaser arrangement with Bank of America, N.A.
The shares will be delivered by the forward purchaser or its affiliate; the company will not receive proceeds from those initial sales. The company expects physical settlement and to receive net proceeds upon one or more forward settlement dates within approximately 24 months, but may instead elect cash or net‑share settlement. Shares are listed on the NYSE under AHR (closing price $50.81 on May 19, 2026). The prospectus discloses an ownership limit of 9.9% and estimates total common stock outstanding after full physical settlement of the forward sale agreement of 206,722,308 shares.
American Healthcare REIT, Inc. entered into an ATM Equity Offering Sales Agreement to offer shares of its common stock having an aggregate gross sales price of up to $1,750,000,000, replacing a prior $1,000,000,000 ATM. Sales may occur from time to time through listed agents and via negotiated or at-the-market transactions.
The company expects to contribute net proceeds to its Operating Partnership in exchange for OP Units and anticipates that forward sale agreements may be used; physical settlement of forwards is expected on or prior to maturity, though cash or net share settlement is permitted under the forward sale terms.
American Healthcare REIT, Inc. is offering 8,100,000 shares of common stock through a forward sale agreement with Royal Bank of Canada, with up to 9,315,000 shares if the underwriter’s option is fully exercised. The forward purchaser or its affiliate will initially borrow and sell the shares to the underwriter at an initial forward sale price of $47.75 per share, and the company will receive no proceeds from that sale.
Assuming full physical settlement of the forward sale agreement within approximately 18 months, the company estimates net cash proceeds of about $386.4 million, or $444.4 million if the option is fully exercised, based on the $47.75 initial forward price. After settlement, total common stock outstanding is expected to be 186,264,566 shares, compared with 178,164,566 shares outstanding as of November 14, 2025.
The company plans to contribute the net proceeds to its operating partnership for general corporate purposes, including potential healthcare real estate investments. As a REIT, it maintains a 9.9% ownership limit on its capital stock to help preserve REIT status, and warns that the forward structure can create dilution and, in certain cash or net share settlement scenarios, potential cash or share obligations to the forward purchaser.
American Healthcare REIT, Inc. is offering 8,100,000 shares of common stock, with an additional 1,215,000-share option, through a forward sale agreement with Royal Bank of Canada. The forward purchaser will borrow and sell the shares now, while the company expects to physically settle the agreement and receive cash proceeds within about 18 months, although it can instead choose cash or net share settlement, which could result in no proceeds and potential cash or share payments to the bank.
Shares outstanding were 178,164,566 as of November 14, 2025, and are expected to be 186,264,566 after full physical settlement. AHR continues to expand, having closed over $575 million of acquisitions in 2025 and holding a $288.5 million pipeline, supported by a $1.0 billion at-the-market program and prior forward sales for 2,153,436 shares.